Udai Banerji
Royal Marsden NHS Foundation Trust
ORCID: 0000-0003-1503-3123Also affiliated with Institute of Cancer Research, Cancer Research UK, London Cancer, Institute of Cancer Research, Royal Marsden Hospital, CRUK Lung Cancer Centre of Excellence
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 6 papers. Top paper: “Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination with Fulvestrant in Patients with AKT1 E17K-Mutant, ER-Positive Metastatic Breast Cancer”.
Kenji Tamura, Mafalda Oliveira, Eva Ciruelos, Ingrid A. Mayer, Marie‐Paule Sablin +23 more
Gerald Batist, Funda Meric‐Bernstam, Peter Kabos, Iben Spanggaard, Aňa Lluch +22 more
Marta Ascanio Morcillo, Juanita Lopez, Anna Minchom, Adam Sharp, Alec Paschalis +4 more
Gaia Giannone, Andrew R. Clamp, Darren P. Ennis, Rosalind M. Glasspool, Rebecca Herbertson +15 more
Daniel Nichol, Javier Fernández-Mateos, George D. Cresswell, Iros Barozzi, Sung Pil Hong +14 more
Lillian L. Siu, Emiliano Calvo, Martijn P. Lolkema, Patricia LoRusso, Jean‐Charles Soria +5 more